Literature DB >> 10707020

Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.

Y Aso1, S Yoshioka, S Kojima.   

Abstract

Isothermal crystallization of amorphous nifedipine, phenobarbital, and flopropione was studied at temperatures above and below their glass transition temperatures (T(g)). A sharp decrease in the crystallization rate with decreasing temperature was observed for phenobarbital and flopropione, such that no crystallization was observed at temperatures 20-30 degrees C lower than their T(g) within ordinary experimental time periods. In contrast, the crystallization rate of nifedipine decreased moderately with decreasing temperature, and considerable crystallization was observed at 40 degrees C below its T(g) within 4 months. The molecular mobility of these amorphous drugs was assessed by enthalpy relaxation and (1)H-NMR relaxation measurements. The enthalpy relaxation time of nifedipine was smaller than that of phenobarbital or flopropinone at the same T - T(g) values, suggesting higher molecular mobility of nifedipine. The spin-lattice relaxation time in the rotating frame (T(1rho)) decreased markedly at temperature above T(g). The slope of the Arrhenius type plot of the T(1rho) for nifedipine protons changed at about 10 degrees C below the T(g), whereas the slope for phenobarbital protons became discontinuous at about 10 degrees C above the T(g). Even at temperatures below its T(g), the spin-spin relaxation process of nifedipine could be described by the sum of its Gaussian relaxation, which is characteristic of solid protons, and its Lorentzian relaxation, which is characteristic of protons with higher mobility. In contrast, no Lorentzian relaxation was observed for phenobarbital or flopropione at temperatures below their T(g). These results also suggest that nifedipine has higher molecular mobility than phenobarbital and flopropione at temperatures below T(g). The faster crystallization of nifedipine than that of phenobarbital or flopropione observed at temperatures below its T(g) may be partly ascribed to its higher molecular mobility at these temperatures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707020     DOI: 10.1002/(SICI)1520-6017(200003)89:3<408::AID-JPS11>3.0.CO;2-#

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.

Authors:  Ting Cai; Lei Zhu; Lian Yu
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

2.  Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times.

Authors:  Katsuhiko Masuda; Sachio Tabata; Yasuyuki Sakata; Tetsuo Hayase; Etsuo Yonemochi; Katsuhide Terada
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

3.  A calorimetric method to estimate molecular mobility of amorphous solids at relatively low temperatures.

Authors:  Chen Mao; Sai Prasanth Chamarthy; Stephen R Byrn; Rodolfo Pinal
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

4.  Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility.

Authors:  Madhav Vasanthavada; Wei-Qin Tong; Yatindra Joshi; M Serpil Kislalioglu
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.

Authors:  Patrick J Marsac; Hajime Konno; Alfred C F Rumondor; Lynne S Taylor
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

6.  Molecular dynamics of amorphous pharmaceutical fenofibrate studied by broadband dielectric spectroscopy.

Authors:  U Sailaja; M Shahin Thayyil; N S Krishna Kumar; G Govindaraj
Journal:  J Pharm Anal       Date:  2014-09-16

7.  Exploring molecular reorientations in amorphous and recrystallized felodipine at the microscopic level.

Authors:  A Pajzderska; J Jenczyk; J P Embs; J Wąsicki
Journal:  RSC Adv       Date:  2020-10-08       Impact factor: 4.036

8.  Exploring the molecular reorientations in amorphous rosuvastatin calcium.

Authors:  N M Belozerova; P Bilski; M Jarek; J Jenczyk; S E Kichanov; D P Kozlenko; J Mielcarek; A Pajzderska; J Wąsicki
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 3.361

Review 9.  Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.

Authors:  Kohsaku Kawakami
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.